Sunday, December 28, 2014

Top 5 Net Payout Yield Companies For 2014

Starbucks has concocted yet another way to shake some spare change out of its mobile phone-carrying customers: digital tipping.

Beginning Wednesday, March 19, customers who use the Starbucks App for iPhone in the U.S., Canada and UK will be able to use the app to leave a tip at more than 7,000 company-operated Starbucks stores.

Until now, consumers could not digitally tip at Starbucks. This has been a problem. Thousands of caffeine-seeking customers who carry their cell phones ��but no cash ��have been stiffing baristas, and not feeling so swell about it.

In fact, digital tipping has been one of the most-frequent suggestions from consumers on the Starbucks idea site,

"As more and more customers are using their phones to pay," says Cliff Burrows, group president, of Starbucks U.S., "they have asked for a convenient and meaningful way" to tip baristas.

5 Best Supermarket Stocks For 2015: Trius Therapeutics Inc.(TSRX)

Trius Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of antibiotics for serious, life-threatening infections in the United States. Its lead product includes Torezolid Phosphate, which is in Phase-III clinical trials for the treatment of serious gram-positive bacterial infections, initially for acute bacterial skin and skin structure infections. The company is also developing antibiotics for gram-negative infections using its proprietary discovery platform under two contracts funded by the National Institute of Allergy and Infectious Diseases, and Defense Threat Reduction Agency. It has a cooperative research and development agreement with Lawrence Livermore National Security LLC for the research and development of gram-negative biodefense pathogens; and a license agreement with Dong-A Pharmaceutical Co., Ltd. to develop and sell Torezolid Phosphate outside of Korea. The company was formerly known as Rx3 Pharmac euticals, Inc. and changed its name to Trius Therapeutics, Inc. in February 2007. Trius Therapeutics, Inc. was founded in 2004 and is headquartered in San Diego, California.

Advisors' Opinion:
  • [By Bob's Stocks]

    Back on February 4th, I wrote an article regarding another antibiotic stock named Trius Therapeutics (TSRX). It was trading at $5.00 per share at the time, and I put a price per share prediction of $13.00. I also stated it was a takeover target. Yesterday, Cubist Pharmaceuticals bought Trius Therapeutics for $13.50 a share. You can read that article here.

Top 5 Net Payout Yield Companies For 2014: Edwards Lifesciences Corporation (EW)

Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. The company offers surgical heart valve therapy products, such as tissue heart valves and repair products, which are used to replace or repair a patient�s diseased or defective heart valve; and produces pericardial and porcine valves. Its surgical heart valve therapy products include Carpentier-Edwards PERIMOUNT pericardial valve that comprise PERIMOUNT Magna Ease valves for aortic and mitral replacement; ThruPort systems that enable minimal incision valve surgery; and protection cannulae used during cardiac surgery in venous drainage, aortic perfusion, venting, and cardioplegia delivery. The company also provides transcatheter heart valves portfolio that includes technologies designed to treat heart valve disease using catheter-based approaches, as well as critical care products, such as hemodynamic monitoring systems to measure a p atient�s heart function in surgical and intensive care settings; Swan-Ganz line of pulmonary artery catheters and PreSep continuous venous oximetry catheters for measuring central venous oxygen saturation; VolumeView sensor-catheters; FloTrac continuous cardiac output monitoring system, a minimally invasive cardiac monitoring technology for goal-directed fluid optimization; and EV1000 clinical monitoring platform, which displays a patient's physiologic status. Its critical care products also include disposable pressure monitoring devices and closed blood sampling systems to help protect both patients and clinicians from the risk of infection; and products used to treat endolumenal occlusive disease, including balloon-tipped, catheter-based embolectomy products, surgical clips, and clamps. The company distributes its products through direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1999 and is headquartered in Irvine, Californi a.

Advisors' Opinion:
  • [By Teresa Rivas]

    Shares of Edward Lifesciences (EW) were climbing as high as 15% in Monday morning trading, after a federal court late Friday sided with the firm in its patent infringement lawsuit against Medtronic�(MDT). The decision stipulated an injunction against the sale of Medtronic�� Transcatheter valves, although the firm plans to appeal the ruling. (Medtronic, by contrast, was falling 4.2%.)

    Analysts were weighing in on the decision today. Canaccord Genuity�� Jason Mills and Jeffery Chu reiterated a Buy rating and $84 price target on the stock, calling the court victory surprising and important:

    While we believe EW has a better chance than we previously thought of being granted a permanent injunction against MDT, we still expect EW to ultimately cash in via other forms of equitable relief in lieu of a final injunction: (1) lump-sum future damages; and (2) continuing royalties. Importantly, none of these potential outcomes are factored into our forward model.

    What�� more, EW will have at least one more shot at winning further concessions from MDT, as EW filed a motion seeking a permanent injunction against MDT following a mid-January finding that MDT willfully infringed EW�� Cribier TAVR patent. A jury awarded EW $393M at that time in this case. We had expected this award to be tied up in appeals for several years; however, EW could use its increased leverage to push MDT to pay sooner.

    Stifel Nicolaus�� Robert Wise and his team were more cautiously positively: While maintaining a Buy rating and $75 price target on the stock, they note that they don�� want to adjust their numbers, as the saga of appeals and counterappeals will likely drag on through the court system for some time (although, if upheld, they note that Friday�� victory would help Edward LIfesciences maintain greater-than-expected market share).

    Their thoughts on the two names:

    MDT Next Steps: Seeking Emergency Stay and Decision Appeal.Medtronic will see

  • [By Keith Speights]

    Has anyone noticed a common theme among the first-quarter results for many of the big medical-device companies? In case you missed earnings announcements from Abbott Labs (NYSE: ABT  ) , Boston Scientific (NYSE: BSX  ) , Edwards Lifesciences (NYSE: EW  ) , Johnson & Johnson (NYSE: JNJ  ) , or Stryker (NYSE: SYK  ) , the following chart shows how their medical-device business fared during the quarter.

Top 5 Net Payout Yield Companies For 2014: Mechel Steel Group OAO (MTL)

Mechel OAO, together with its subsidiaries, engages in mining and steel businesses in the Russian Federation, other CIS countries, Europe, Asia, the Middle East, the United States, and internationally. The company operates through four segments: Mining, Steel, Ferroalloys, and Power. The Mining segment engages in the production and sale of metallurgical and steam coal, coke, iron ore, and limestone, as well as chemical products, such as coal tar, naphthalene, and other compounds. The Steel segment produces and sells semi-finished steel products, carbon and special long products, and carbon and stainless flat products, as well as metal products, including wire products, forgings, and stampings. The Ferroalloys segment is involved in the production and sale of nickel ore, low-ferrous ferronickel, ferrochrome, and ferrosilicon. The Power segment engages in the generation and sale of electricity and heat energy from steam coal; and power distribution activities. The company, f ormerly known as Mechel Steel Group OAO, was founded in 2003 and is based in Moscow, the Russian Federation.

Advisors' Opinion:
  • [By Jake L'Ecuyer]

    Mechel OAO (NYSE: MTL) was down, falling 2.33 percent to $2.52 after the company appointed Senior Vice-President for Economics and Management Oleg Korzhov as its Chief Executive Officer.

  • [By Eric Volkman]

    The coffers of Mechel (NYSE: MTL  ) are now much fuller. The company has signed an agreement for a 40 billion ruble ($1.3 billion) loan from VTB Bank, a lender based in Mechel's home base of Russia. Of the total, roughly 25 billion ($802 million) will go toward the servicing of short-term facilities coming due in 2013. It also aims to refinance other debt obligations with the monies.

Top 5 Net Payout Yield Companies For 2014: Inc (AMZ), Inc. (, incorporated on May 28, 1996, serves consumers through its retail websites and focus on selection, price, and convenience. The Company offers programs that enables sellers to sell their products on its Websites and their own branded Websites and to fulfill orders through them , and programs that allow authors, musicians, filmmakers, application developers, and others to publish and sell content. The Company operates in two segments: North America and International. The Company serves consumers through its retail websites, and focus on selection, price, and convenience. The Company designs its Websites to enable millions of products to be sold by the Company and by third parties across dozens of product categories. Customers access its Websites directly and through its mobile Websites and apps. It also manufactures and sells Kindle devices. In May 2012, the Company acquired Kiva Systems, Inc. (Kiva). In October 2013, Inc acquired TenMarks Education Inc. Effective February 5, 2014, Inc acquired Double Helix Games LLC. Effective May 6, 2014, the Company acquired Iconology Inc.

The Company offers its customers the lowest prices possible through low everyday product pricing and shipping offers, including through membership in Amazon Prime, and to improve its operating efficiencies so that it can continue to lower prices for its customers. The Company also provides easy-to-use functionality, fast and reliable fulfillment, and timely customer service. It offers programs that enable sellers to sell their products on its websites and their own branded websites and to fulfill orders through them.

The Company serves developers and enterprises of all sizes through Amazon Web Services (AWS), which provides access to technology infrastructure that enables virtually any type of business. The Company serves serve authors and independent publishers with Kindle Direct Publishing. It also offers programs that allow authors, musicians, filmmak! ers, app developers, and others to publish and sell content.

North America

North America segment consists of amounts earned from retail sales of consumer products and subscriptions through North America-focused websites such as and and include amounts earned from AWS. This segment includes export sales from and


The International segment consists of amounts earned from retail sales of consumer products and subscriptions through internationally-focused websites. This segment includes export sales from these internationally based websites , including export sales from these sites to customers in the U.S. and Canada.

Advisors' Opinion:
  • [By Charles Sizemore]

    For an asset class once known for stable dividends backed by recurring revenues from long term contracts, MLPs have turned into investment divas ��strong performers with lots of volatility. The Alerian MLP Index (AMZ) outperformed the S&P 500 in 2009, 2010, and 2011 ��and despite the huge move in the broad market last year, came close to matching the S&P 500 in 2013 (27.59% vs. 32.38%). The MLP index is still ahead of the S&P 500 year to date after rebounding from a massive sell-off in October. Still, AMZ is below levels of the late summer and early fall.

No comments:

Post a Comment